SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Columbia Care Inc. (OTC – CCHWF)

BALA CYNWYD – March 28, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Columbia Care Inc. (“Columbia Care” or the “Company”) (OTC – CCHWF) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company’s agreement to be acquired by Cresco Labs (“Cresco Labs”) (OTC – CRLBF). Under the terms of the Arrangement Agreement, shareholders of Columbia Care will receive 0.5579 of a subordinate voting share of Cresco Labs for each Columbia Care common share held, subject to adjustment, representing total consideration enterprise value of approximately $2 billion based on the closing price of Cresco Labs shares on the Canadian Securities Exchange as of March 22, 2022.

The investigation concerns whether the Columbia Care Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Cresco Labs is paying too little for the Company.

If you own shares of Columbia Care stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.